3.20.2 html 268 343 1 false 50 0 false 7 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.cytosorbents.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.cytosorbents.com/role/StatementConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.cytosorbents.com/role/StatementConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://www.cytosorbents.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 00300 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.cytosorbents.com/role/StatementConsolidatedStatementOfChangesInStockholdersEquity CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.cytosorbents.com/role/StatementConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 10101 - Disclosure - BASIS OF PRESENTATION Sheet http://www.cytosorbents.com/role/DisclosureBasisOfPresentation BASIS OF PRESENTATION Notes 7 false false R8.htm 10201 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.cytosorbents.com/role/DisclosurePrincipalBusinessActivityAndSummaryOfSignificantAccountingPolicies PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 10301 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.cytosorbents.com/role/DisclosureStockholdersEquity STOCKHOLDERS' EQUITY Notes 9 false false R10.htm 10401 - Disclosure - REVENUE Sheet http://www.cytosorbents.com/role/DisclosureRevenue REVENUE Notes 10 false false R11.htm 10501 - Disclosure - LONG-TERM DEBT, NET Sheet http://www.cytosorbents.com/role/DisclosureLongTermDebtNet LONG-TERM DEBT, NET Notes 11 false false R12.htm 10601 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.cytosorbents.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 12 false false R13.htm 10701 - Disclosure - LEASES Sheet http://www.cytosorbents.com/role/DisclosureLeases LEASES Notes 13 false false R14.htm 10801 - Disclosure - NET LOSS PER SHARE Sheet http://www.cytosorbents.com/role/DisclosureNetLossPerShare NET LOSS PER SHARE Notes 14 false false R15.htm 10901 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.cytosorbents.com/role/DisclosureSubsequentEvents SUBSEQUENT EVENTS Notes 15 false false R16.htm 20202 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.cytosorbents.com/role/DisclosurePrincipalBusinessActivityAndSummaryOfSignificantAccountingPoliciesPolicies PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 16 false false R17.htm 30303 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://www.cytosorbents.com/role/DisclosureStockholdersEquityTables STOCKHOLDERS' EQUITY (Tables) Tables http://www.cytosorbents.com/role/DisclosureStockholdersEquity 17 false false R18.htm 30403 - Disclosure - REVENUE (Tables) Sheet http://www.cytosorbents.com/role/DisclosureRevenueTables REVENUE (Tables) Tables http://www.cytosorbents.com/role/DisclosureRevenue 18 false false R19.htm 30503 - Disclosure - LONG-TERM DEBT, NET (Tables) Sheet http://www.cytosorbents.com/role/DisclosureLongTermDebtNetTables LONG-TERM DEBT, NET (Tables) Tables http://www.cytosorbents.com/role/DisclosureLongTermDebtNet 19 false false R20.htm 30703 - Disclosure - LEASES (Tables) Sheet http://www.cytosorbents.com/role/DisclosureLeasesTables LEASES (Tables) Tables http://www.cytosorbents.com/role/DisclosureLeases 20 false false R21.htm 40101 - Disclosure - BASIS OF PRESENTATION (Details) Sheet http://www.cytosorbents.com/role/DisclosureBasisOfPresentationDetails BASIS OF PRESENTATION (Details) Details http://www.cytosorbents.com/role/DisclosureBasisOfPresentation 21 false false R22.htm 40201 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.cytosorbents.com/role/DisclosurePrincipalBusinessActivityAndSummaryOfSignificantAccountingPoliciesDetails PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.cytosorbents.com/role/DisclosurePrincipalBusinessActivityAndSummaryOfSignificantAccountingPoliciesPolicies 22 false false R23.htm 40301 - Disclosure - STOCKHOLDERS' EQUITY - Stock option activity (Details) Sheet http://www.cytosorbents.com/role/DisclosureStockholdersEquityStockOptionActivityDetails STOCKHOLDERS' EQUITY - Stock option activity (Details) Details 23 false false R24.htm 40302 - Disclosure - STOCKHOLDERS' EQUITY - Intrinsic value (Details) Sheet http://www.cytosorbents.com/role/DisclosureStockholdersEquityIntrinsicValueDetails STOCKHOLDERS' EQUITY - Intrinsic value (Details) Details 24 false false R25.htm 40303 - Disclosure - STOCKHOLDERS' EQUITY - Non-vested options (Details) Sheet http://www.cytosorbents.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails STOCKHOLDERS' EQUITY - Non-vested options (Details) Details 25 false false R26.htm 40304 - Disclosure - STOCKHOLDERS' EQUITY - Restricted stock unit (Details) Sheet http://www.cytosorbents.com/role/DisclosureStockholdersEquityRestrictedStockUnitDetails STOCKHOLDERS' EQUITY - Restricted stock unit (Details) Details 26 false false R27.htm 40305 - Disclosure - STOCKHOLDERS' EQUITY - Restricted stock unit activity (Details) Sheet http://www.cytosorbents.com/role/DisclosureStockholdersEquityRestrictedStockUnitActivityDetails STOCKHOLDERS' EQUITY - Restricted stock unit activity (Details) Details 27 false false R28.htm 40306 - Disclosure - STOCKHOLDERS' EQUITY - Additional information (Details) Sheet http://www.cytosorbents.com/role/DisclosureStockholdersEquityAdditionalInformationDetails STOCKHOLDERS' EQUITY - Additional information (Details) Details 28 false false R29.htm 40401 - Disclosure - REVENUE - Revenue by customer type and geographic area (Details) Sheet http://www.cytosorbents.com/role/DisclosureRevenueRevenueByCustomerTypeAndGeographicAreaDetails REVENUE - Revenue by customer type and geographic area (Details) Details 29 false false R30.htm 40402 - Disclosure - REVENUE - Receivables and contract liabilities (Details) Sheet http://www.cytosorbents.com/role/DisclosureRevenueReceivablesAndContractLiabilitiesDetails REVENUE - Receivables and contract liabilities (Details) Details 30 false false R31.htm 40403 - Disclosure - REVENUE - Additional information (Details) Sheet http://www.cytosorbents.com/role/DisclosureRevenueAdditionalInformationDetails REVENUE - Additional information (Details) Details 31 false false R32.htm 40501 - Disclosure - LONG-TERM DEBT, NET - Letter success fee (Details) Sheet http://www.cytosorbents.com/role/DisclosureLongTermDebtNetLetterSuccessFeeDetails LONG-TERM DEBT, NET - Letter success fee (Details) Details 32 false false R33.htm 40502 - Disclosure - LONG-TERM DEBT, NET - Principal payments (Details) Sheet http://www.cytosorbents.com/role/DisclosureLongTermDebtNetPrincipalPaymentsDetails LONG-TERM DEBT, NET - Principal payments (Details) Details 33 false false R34.htm 40503 - Disclosure - LONG-TERM DEBT, NET - Additional information (Details) Sheet http://www.cytosorbents.com/role/DisclosureLongTermDebtNetAdditionalInformationDetails LONG-TERM DEBT, NET - Additional information (Details) Details 34 false false R35.htm 40601 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.cytosorbents.com/role/DisclosureCommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://www.cytosorbents.com/role/DisclosureCommitmentsAndContingencies 35 false false R36.htm 40701 - Disclosure - LEASES - ROU and Lease liability (Details) Sheet http://www.cytosorbents.com/role/DisclosureLeasesRouAndLeaseLiabilityDetails LEASES - ROU and Lease liability (Details) Details 36 false false R37.htm 40702 - Disclosure - LEASES - Maturities of Lease liabilities (Details) Sheet http://www.cytosorbents.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails LEASES - Maturities of Lease liabilities (Details) Details 37 false false R38.htm 40703 - Disclosure - LEASES - Additional Information (Details) Sheet http://www.cytosorbents.com/role/DisclosureLeasesAdditionalInformationDetails LEASES - Additional Information (Details) Details 38 false false R39.htm 40801 - Disclosure - NET LOSS PER SHARE (Details) Sheet http://www.cytosorbents.com/role/DisclosureNetLossPerShareDetails NET LOSS PER SHARE (Details) Details http://www.cytosorbents.com/role/DisclosureNetLossPerShare 39 false false R40.htm 40901 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.cytosorbents.com/role/DisclosureSubsequentEventsDetails SUBSEQUENT EVENTS (Details) Details http://www.cytosorbents.com/role/DisclosureSubsequentEvents 40 false false All Reports Book All Reports ctso-20200930x10q.htm ctso-20200930.xsd ctso-20200930_cal.xml ctso-20200930_def.xml ctso-20200930_lab.xml ctso-20200930_pre.xml ctso-20200930xex31d1.htm ctso-20200930xex31d2.htm ctso-20200930xex32d1.htm ctso-20200930xex32d2.htm http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 http://fasb.org/srt/2020-01-31 true true